Gainers
Imago BioSciences, Inc. (NASDAQ: IMGO) shares climbed 104.5% to close at $35.59 on Monday after Merck announced it would acquire the company for $36 per share in cash.
Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation
Werth Family Investment Associates Provides $5 Million of Debt Financing
Cingulate received $5 million of debt financing from Werth Family Investment Associates LLC (WFIA). The promissory note